Advertisement

Topics

Molecular medicine in lung cancer

12:04 EDT 3 Jul 2017 | ecancermedicalscience

Dr Büttner speaks with ecancer at WIN 2017 about determining vulnerabilities to targeted or immune therapeutics in lung cancer through Network Genomic Medicine. He discusses the landmark successes of PD-1 checkpoint therapy for lung cancer, and...

Original Article: Molecular medicine in lung cancer

NEXT ARTICLE

More From BioPortfolio on "Molecular medicine in lung cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Lung Cancer
Lung cancer is the uncontrolled cell growth in tissues of the lung. Originating in the lungs, this growth may invade adjacent tissues and infiltrate beyond the lungs. Lung cancer, the most common cause of cancer-related death in men and women, is respons...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...